Our Reproductive Endocrinologists are involved in clinical trials, which result in publications and invitations for guest lecturing on topics covering the entire spectrum of Assisted Reproductive Technologies, Reconstructive Pelvic Surgeries and Reproductive Immunology.

We are currently evaluating a clinical protocol intended to eliminate the risk of high order multiple pregnancies in ART. This effort includes the valuation of a novel embryo transfer grading system and the use of several culture media to maximize blastocyst development. Our goal is to eventually offer single embryo transfer without compromise to outcome potential.

If you are interest in participating on one of our studies, call us for more information.